+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Disopyramide Market by Form (Capsule, Solution), Action Mechanism (Antagonist, Inhibitor), Indication, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967896
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Disopyramide Market size was estimated at USD 245.82 million in 2023, USD 257.28 million in 2024, and is expected to grow at a CAGR of 4.86% to reach USD 342.91 million by 2030.

Disopyramide is a medication primarily used to treat certain types of serious irregular heartbeats (arrhythmias) such as atrial fibrillation. It functions by restoring normal heart rhythms and maintaining a regular, steady heartbeat, classified as a Class IA antiarrhythmic agent. Factors contributing to its expanded use include an aging population prone to cardiovascular diseases, advancements in diagnostic technologies enabling timely detection of arrhythmias, and a growing emphasis on preventive healthcare. However, disopyramide does have disadvantages, including potential side effects such as dry mouth, constipation, urinary retention, and heart failure.

Due to its interaction with other medications and potential exacerbation of existing conditions, its usage must be carefully monitored. Furthermore, the market opportunities for disopyramide include formulation improvements to minimize side effects, the development of combination therapies with other cardiovascular drugs to enhance efficacy, and expansion in emerging markets where there is increasing awareness and access to treatments for heart conditions. Moreover, ongoing research into the molecular mechanisms of arrhythmias could lead to innovations in disopyramide usage or the development of novel therapeutic alternatives.

Regional Insights

In the Americas, the United States remains a pivotal market, fueled by a well-established healthcare system and a substantial prevalence of cardiac disorders, which necessitates ongoing access to treatments like disopyramide. Patients benefit from a system enhanced by stringent FDA oversight that promotes continuous pharmaceutical innovation, including safety studies post-commercialization. In contrast, Canada's universal healthcare system ensures wide accessibility to such medications, supported by substantial governmental healthcare investments. The market dynamics for disopyramide in the EU vary, as healthcare systems and regulations differ significantly across member countries.

However, the European Medicines Agency (EMA) provides a centralized regulatory framework that can streamline approvals and distributions of medications across Europe. This pan-European approach helps stabilize demand and consumer behavior across different countries. In the Asia Pacific, disparities in healthcare maturity create diverse market landscapes. China is rapidly enhancing its healthcare framework and boosting local drug production, increasing accessibility to disopyramide. Japan, known for its cutting-edge healthcare system, maintains stable market demand through high trust in healthcare practices and continuous innovation. Meanwhile, India leverages its robust generic drug industry to meet significant demands for affordable medications, supported by governmental efforts to enhance healthcare reach.

Market Trends by Segment

  • Form: Preference towards capsule due to its convenience and the ability to maintain steady drug levels over time
  • Distribution Channel: Expansion of online distribution due to its safety, convenience, and accessibility

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Cytokinetics Reports Encouraging Outcomes from Latest REDWOOD-HCM Cohort Study

Cytokinetics announced positive preliminary results from the third cohort of its REDWOOD-HCM (Hypertrophic Cardiomyopathy) study, which assessed the efficacy and safety of their leading drug candidate, disopyramide. The study aims to explore alternative therapies for individuals living with hypertrophic cardiomyopathy, a condition characterized by the thickening of the heart muscle which can lead to various cardiac symptoms and complications.

Key Company Profiles

The report delves into recent significant developments in the Disopyramide Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca plc, Dr. Reddy's Labratories Inc., Merck & Co., Inc., Novartis Group, Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., The Bristol-Myers Squibb Company, and Viatris Inc.

This research report offers invaluable insights into various crucial aspects of the Disopyramide Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing aging population prone to cardiovascular diseases
5.1.1.2. Increased public health initiatives and screening for heart diseases
5.1.2. Restraints
5.1.2.1. Product recall and safety concerns associated with disopyramide
5.1.3. Opportunities
5.1.3.1. Technological advancements in drug delivery systems to increase the ease of administration
5.1.3.2. Development of combination therapies with other cardiovascular drugs to enhance efficacy
5.1.4. Challenges
5.1.4.1. Side effects associated with disopyramide
5.2. Market Segmentation Analysis
5.2.1. Form: Preference towards capsule due to its convenience and the ability to maintain steady drug levels over time
5.2.2. Distribution Channel: Expansion of online distribution due to its safety, convenience, and accessibility
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Disopyramide Market, by Form
6.1. Introduction
6.2. Capsule
6.3. Solution
7. Disopyramide Market, by Action Mechanism
7.1. Introduction
7.2. Antagonist
7.3. Inhibitor
8. Disopyramide Market, by Indication
8.1. Introduction
8.2. Cardiac Dysrhythmias
8.3. Ventricular Pre-excitation
8.4. Ventricular Tachycardia
9. Disopyramide Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Disopyramide Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Disopyramide Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Disopyramide Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Cytokinetics Reports Encouraging Outcomes from Latest REDWOOD-HCM Cohort Study
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. DISOPYRAMIDE MARKET RESEARCH PROCESS
FIGURE 2. DISOPYRAMIDE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DISOPYRAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DISOPYRAMIDE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL DISOPYRAMIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DISOPYRAMIDE MARKET DYNAMICS
FIGURE 7. GLOBAL DISOPYRAMIDE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 8. GLOBAL DISOPYRAMIDE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2023 VS 2030 (%)
FIGURE 10. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. GLOBAL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. DISOPYRAMIDE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. DISOPYRAMIDE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DISOPYRAMIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DISOPYRAMIDE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL DISOPYRAMIDE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL DISOPYRAMIDE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL DISOPYRAMIDE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL DISOPYRAMIDE MARKET SIZE, BY EXTENDED-RELEASE CAPSULES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL DISOPYRAMIDE MARKET SIZE, BY EXTENDED-RELEASE CAPSULES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL DISOPYRAMIDE MARKET SIZE, BY IMMEDIATE-RELEASE CAPSULES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL DISOPYRAMIDE MARKET SIZE, BY IMMEDIATE-RELEASE CAPSULES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL DISOPYRAMIDE MARKET SIZE, BY SOLUTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL DISOPYRAMIDE MARKET SIZE, BY SOLUTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ANTAGONIST, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ANTAGONIST, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL DISOPYRAMIDE MARKET SIZE, BY INHIBITOR, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL DISOPYRAMIDE MARKET SIZE, BY INHIBITOR, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL DISOPYRAMIDE MARKET SIZE, BY CARDIAC DYSRHYTHMIAS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL DISOPYRAMIDE MARKET SIZE, BY CARDIAC DYSRHYTHMIAS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL DISOPYRAMIDE MARKET SIZE, BY VENTRICULAR PRE-EXCITATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL DISOPYRAMIDE MARKET SIZE, BY VENTRICULAR PRE-EXCITATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL DISOPYRAMIDE MARKET SIZE, BY VENTRICULAR TACHYCARDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL DISOPYRAMIDE MARKET SIZE, BY VENTRICULAR TACHYCARDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL DISOPYRAMIDE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL DISOPYRAMIDE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL DISOPYRAMIDE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL DISOPYRAMIDE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL DISOPYRAMIDE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 73. CANADA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 74. CANADA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 75. CANADA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 76. CANADA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 77. CANADA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 78. CANADA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 79. CANADA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 80. CANADA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 81. CANADA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 82. CANADA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 83. MEXICO DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 84. MEXICO DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 85. MEXICO DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 86. MEXICO DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 87. MEXICO DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 88. MEXICO DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 89. MEXICO DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 90. MEXICO DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 91. MEXICO DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 92. MEXICO DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES DISOPYRAMIDE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 117. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 118. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 119. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 120. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 121. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 122. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 123. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 124. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 125. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 126. AUSTRALIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 127. CHINA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 128. CHINA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 129. CHINA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 130. CHINA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 131. CHINA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 132. CHINA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 133. CHINA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 134. CHINA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 135. CHINA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 136. CHINA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 137. INDIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 138. INDIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 139. INDIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 140. INDIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 141. INDIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 142. INDIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 143. INDIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 144. INDIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 145. INDIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 146. INDIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 147. INDONESIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 148. INDONESIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 149. INDONESIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 150. INDONESIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 151. INDONESIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 152. INDONESIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 153. INDONESIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 154. INDONESIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 155. INDONESIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 156. INDONESIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 157. JAPAN DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 158. JAPAN DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 159. JAPAN DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 160. JAPAN DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 161. JAPAN DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 162. JAPAN DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 163. JAPAN DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 164. JAPAN DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 165. JAPAN DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 166. JAPAN DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 167. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 168. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 169. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 170. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 171. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 172. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 173. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 174. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 175. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 176. MALAYSIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 177. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 178. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 179. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 180. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 181. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 182. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 183. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 184. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 185. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 186. PHILIPPINES DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 187. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 188. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 189. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 190. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 191. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 192. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 193. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 194. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 195. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 196. SINGAPORE DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 197. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 198. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 199. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 200. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 201. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 202. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 203. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 204. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 205. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 206. SOUTH KOREA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 207. TAIWAN DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 208. TAIWAN DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 209. TAIWAN DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 210. TAIWAN DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 211. TAIWAN DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 212. TAIWAN DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 213. TAIWAN DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 214. TAIWAN DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 215. TAIWAN DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 216. TAIWAN DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 217. THAILAND DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 218. THAILAND DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 219. THAILAND DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 220. THAILAND DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 221. THAILAND DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 222. THAILAND DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 223. THAILAND DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 224. THAILAND DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 225. THAILAND DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 226. THAILAND DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 227. VIETNAM DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 228. VIETNAM DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 229. VIETNAM DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 230. VIETNAM DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 231. VIETNAM DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 232. VIETNAM DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 233. VIETNAM DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 234. VIETNAM DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 235. VIETNAM DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 236. VIETNAM DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA DISOPYRAMIDE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 249. DENMARK DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 250. DENMARK DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 251. DENMARK DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 252. DENMARK DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 253. DENMARK DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 254. DENMARK DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 255. DENMARK DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 256. DENMARK DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 257. DENMARK DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 258. DENMARK DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 259. EGYPT DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 260. EGYPT DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 261. EGYPT DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 262. EGYPT DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 263. EGYPT DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 264. EGYPT DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 265. EGYPT DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 266. EGYPT DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 267. EGYPT DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 268. EGYPT DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 269. FINLAND DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 270. FINLAND DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 271. FINLAND DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 272. FINLAND DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 273. FINLAND DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 274. FINLAND DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 275. FINLAND DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 276. FINLAND DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 277. FINLAND DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 278. FINLAND DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 279. FRANCE DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 280. FRANCE DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 281. FRANCE DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 282. FRANCE DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 283. FRANCE DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 284. FRANCE DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 285. FRANCE DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 286. FRANCE DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 287. FRANCE DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 288. FRANCE DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 289. GERMANY DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 290. GERMANY DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 291. GERMANY DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 292. GERMANY DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 293. GERMANY DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 294. GERMANY DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 295. GERMANY DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 296. GERMANY DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 297. GERMANY DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 298. GERMANY DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 299. ISRAEL DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 300. ISRAEL DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 301. ISRAEL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 302. ISRAEL DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 303. ISRAEL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 304. ISRAEL DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 305. ISRAEL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 306. ISRAEL DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 307. ISRAEL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 308. ISRAEL DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 309. ITALY DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 310. ITALY DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 311. ITALY DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 312. ITALY DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 313. ITALY DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 314. ITALY DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 315. ITALY DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 316. ITALY DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 317. ITALY DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 318. ITALY DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 319. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 320. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 321. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 322. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 323. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 324. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 325. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 326. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 327. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 328. NETHERLANDS DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 329. NIGERIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 330. NIGERIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 331. NIGERIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 332. NIGERIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 333. NIGERIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 334. NIGERIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 335. NIGERIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 336. NIGERIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 337. NIGERIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 338. NIGERIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 339. NORWAY DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 340. NORWAY DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 341. NORWAY DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 342. NORWAY DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 343. NORWAY DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 344. NORWAY DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 345. NORWAY DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 346. NORWAY DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 347. NORWAY DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 348. NORWAY DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 349. POLAND DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 350. POLAND DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 351. POLAND DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 352. POLAND DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 353. POLAND DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 354. POLAND DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 355. POLAND DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 356. POLAND DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 357. POLAND DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 358. POLAND DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 359. QATAR DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 360. QATAR DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 361. QATAR DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 362. QATAR DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 363. QATAR DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 364. QATAR DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 365. QATAR DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 366. QATAR DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 367. QATAR DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 368. QATAR DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 369. RUSSIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 370. RUSSIA DISOPYRAMIDE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 371. RUSSIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2018-2023 (USD MILLION)
TABLE 372. RUSSIA DISOPYRAMIDE MARKET SIZE, BY CAPSULE, 2024-2030 (USD MILLION)
TABLE 373. RUSSIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2018-2023 (USD MILLION)
TABLE 374. RUSSIA DISOPYRAMIDE MARKET SIZE, BY ACTION MECHANISM, 2024-2030 (USD MILLION)
TABLE 375. RUSSIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 376. RUSSIA DISOPYRAMIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 377. RUSSIA DISOPYRAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 378. RUSSIA DISOPYRAMIDE MARKET SIZE, BY DISTRIB

Companies Mentioned

  • AstraZeneca plc
  • Dr. Reddy's Labratories Inc.
  • Merck & Co., Inc.
  • Novartis Group
  • Pfizer Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • The Bristol-Myers Squibb Company
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information